Slide Insurance Holdings, Inc.
Filed May 23, 2025.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed May 23, 2025
Contents
Cover page
Show cover page
S-11 d739486ds1.htm S-1
As filed with the Securities and Exchange Commission on May 23, 2025.
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
**FORMS-1 **
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
SLIDE INSURANCE HOLDINGS, INC.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 7372 | 871554861 |
|---|---|---|
| (State or Other Jurisdiction ofIncorporation or Organization) | (Primary Standard IndustrialClassification Code Number) | (I.R.S. EmployerIdentification Number) |
4221 W. Boy Scout Blvd.
Suite 200
Tampa, Florida 33607
**(813)748-2030 **
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)
Bruce Lucas
Chief Executive Officer
4221 W. Boy Scout Blvd.
Suite 200
Tampa, Florida 33607
**(713)927-4538 **
(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service)
Copies to:
| Richard D. Truesdell, Jr. Stephen A. Byeff Joseph S. PayneDavis Polk & Wardwell LLP450 Lexington AvenueNew York, New York 10017(212) 450-4000 | Fred E. Karlinsky Greenberg Traurig, LLP 401 E. Las Olas Boulevard, Suite 2000 Fort Lauderdale, Florida 33301 (954) 765-0500 | Gregory A. Fernicola Todd E. Freed Dwight S. Yoo Skadden, Arps, Slate, Meagher & Flom LLPOne Manhattan WestNew York, New York 10001(212) 735-3000 |
|---|
Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement.
If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☐
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, anon-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
|---|---|---|---|
| Non-accelerated filer | ☒ | Smaller reporting company | ☐ |
| Emerging growth company | ☒ | ||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
The Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and we are not soliciting offers to buy these securities in any state where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED , 2025
PRELIMINARY PROSPECTUS
** Shares**
$ per share
This is the initial public offering of common stock of Slide Insurance Holdings, Inc. (“Slide”). We are offering shares of our common stock. The selling stockholders identified in this prospectus, including certain of our directors and officers, are offering an additional shares of our common stock. Slide will not receive any proceeds from the sale of shares of our common stock by the selling stockholders.
Prior to this offering, there has been no public market for our common stock. We anticipate that the initial public offering price of our common stock will be between $ and $ per share.
We have applied to list our common stock on the Nasdaq Global Select Market (“Nasdaq”) under the symbol “SLDE.”
Investing in our common stock involves risks. See “Risk Factors” beginning on page 17.
We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act and will therefore be subject to reduced reporting requirements. See “Prospectus Summary—Implications of Being an Emerging Growth Company.”
Neither the Securities and Exchange Commission nor any state securities commission or regulatory authority has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| Per Share | Total | ||
| Initial public offering price | $ | $ | |
|---|---|---|---|
| Underwriting discounts and commissions | $ | $ | |
| Proceeds to Slide before expenses(1) | $ | $ | |
| Proceeds to the selling stockholders before expenses | $ | $ |
| (1) | We have agreed to reimburse the underwriters for certain FINRA-related expenses. See “Underwriting.” |
The selling stockholders have granted the underwriters the right to purchase an additional shares of common stock to cover over-allotments.
At our request, the underwriters have reserved up to % of the shares of common stock offered by this prospectus for sale, at the initial public offering price, to certain individuals associated with us and our stockholders. See “Underwriting—Directed Share Program.”
The underwriters expect to deliver the shares to purchasers on or about , 2025 through the book-entry facilities of The Depository Trust Company.
| Barclays | Morgan Stanley |
|---|
** , 2025**
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.